Article Information
History
- March 13, 2023.
Article Versions
- Version 1 (July 26, 2022 - 06:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- aDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
- bFSHD Society, Randolph, MA 02368, USA
- cDepartment of Neurology, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA
- dDepartment of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA
- eRNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
- ↵*Correspondence to: Sujatha Jagannathan, University of Colorado, 12801 E. 17th Avenue, Room 10101, Aurora, CO 80045, USA. Tel.: +1303 724 3309 ; E-mail: sujatha.jagannathan{at}cuanschutz.edu.
Posted March 13, 2023.
A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics
